Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06083350
NA

Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment

Sponsor: Xiaofan Xu

View on ClinicalTrials.gov

Summary

Patients with mild cognitive impairment aged 50-80 years old were recruited in Shiyan City, Hubei Province, and divided into intervention group and placebo group. They were given yeast β-glucan capsules and starch capsules, respectively, for 6 months, in order to explore whether yeast β-glucan can improve cognitive function of patients with mild cognitive impairment by regulating gut microbiota and its metabolites.

Official title: A Randomized Controlled Trial of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment

Key Details

Gender

All

Age Range

50 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

144

Start Date

2023-06-27

Completion Date

2025-06-30

Last Updated

2024-05-14

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Yeast beta-glucan

Produced by Angel Yeast Co., LTD

DIETARY_SUPPLEMENT

Starch

Produced by Angel Yeast Co., LTD

Locations (2)

Sinopharm Dongfeng General Hospital

Shiyan, Hubei, China

Huazhong University of Science and Technology

Wuhan, Hubei, China